Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Will Shareholders Support The Bristol/Celgene Merger? – An Informa Pharma Intelligence Podcast

Mar 29 2019

• By Mandy Jackson

Man hand with pen over document, select Yes or No.

Related Content

Keeping Track: Two Goal Date Extensions, Another Herceptin Biosimilar Approval, And A BLA Withdrawal

Mar 15 2019

Bristol Values Celgene's Hematology, Immunology Portfolio At $74bn, But Does It Price In Risk?

Jan 04 2019

Celgene Gives Reassurances That Key Products And Programs Remain On Track

Feb 01 2019

Celgene/Bristol: Happy Union Or Runaway Bride?

Feb 28 2019

J&J Foresees Broad Insurance Coverage For Groundbreaking Spravato Nasal Spray

Mar 07 2019

Related Companies

Karyopharm Therapeutics

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Johnson & Johnson

Alvogen, Inc.

Natco Pharma Limited

Additional Topics

Deals Business Strategies Intellectual Property Companies Legal Issues Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.